Dyne Therapeutics (DYN) Climbs 11.8% on Triple-Digit Price Target Upgrade [Yahoo! Finance]
Dyne Therapeutics, Inc. (DYN)
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm
Check Earnings Report
US:NYSE Investor Relations:
dynegy.com/investors/presentations-events
Company Research
Source: Yahoo! Finance
Dyne Therapeutics saw its share prices jump by 11.81 percent on Tuesday to close at $19.78 apiece, after an investment firm reiterated a triple-digit upside potential for its stock. In a market report, Jefferies reiterated its “buy” issuance for Dyne Therapeutics Inc. (NASDAQ:DYN), alongside a $50 price target. The figure represented a 153 percent upside potential from its latest closing price. medicine Photo by Pietro Jeng on Pexels Jefferies said that the rating reflected its confidence for the accelerated approval of its therapy candidate for DM1. On Monday, Dyne Therapeutics Inc. (NASDAQ:DYN) announced that it would officially initiate the third phase of its trial to study the efficacy of zeleciment basivarsen in patients with DM1, following the successful second phase study. Called the Harmonia trial, the study would enroll 150 participants aged 16 and above, who will be randomized 1:1 to receive 6.8 mg/kg of z-basivarsen or placebo every eight weeks (Q8W). The stu
Show less
Read more
Impact Snapshot
Event Time:
DYN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DYN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DYN alerts
High impacting Dyne Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
DYN
News
- Dyne Therapeutics Advances Rare Disease Pipeline With Pivotal Trials And Data [Yahoo! Finance]Yahoo! Finance
- Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs [Yahoo! Finance]Yahoo! Finance
- Dyne Therapeutics, Inc. (DYN) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript [Seeking Alpha]Seeking Alpha
- Dyne Therapeutics (DYN) had its "buy" rating reaffirmed by Chardan Capital. They now have a $38.00 price target on the stock.MarketBeat
- Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case [Seeking Alpha]Seeking Alpha
DYN
Earnings
- 3/2/26 - Miss
DYN
Sec Filings
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- 3/11/26 - Form 4
- DYN's page on the SEC website